Rating Rationale
August 30, 2022 | Mumbai
Delta Finochem Private Limited
Ratings upgraded to 'CRISIL BBB+/Stable/CRISIL A2'
 
Rating Action
Total Bank Loan Facilities RatedRs.51.5 Crore (Reduced from Rs.88.55 Crore)
Long Term RatingCRISIL BBB+/Stable (Upgraded from 'CRISIL BBB/Positive')
Short Term RatingCRISIL A2 (Upgraded from 'CRISIL A3+')
Note: None of the Directors on CRISIL Ratings Limited’s Board are members of rating committee and thus do not participate in discussion or assignment of any ratings. The Board of Directors also does not discuss any ratings at its meetings.
1 crore = 10 million
Refer to Annexure for Details of Instruments & Bank Facilities

Detailed rationale

CRISIL Ratings has upgraded its ratings on the bank facilities of Delta Finochem Private Limited (DFPL) to CRISIL BBB+/Stable/CRISIL A2’ from 'CRISIL BBB/Positive/CRISIL A3+’. CRISIL Ratings has also withdrawn its rating on proposed long term bank loan facility of Rs.37.05 Crores at company’s request. The withdrawal is in-line with CRISIL Rating’s policy on withdrawal of bank loan ratings.

 

The rating action factors in expected growth in revenue over the medium term and stable operating margin. Operating performance improved in fiscal 2022, as reflected in revenue and operating margin of Rs 306 crore and 12.8%, respectively, as against Rs 243 crore and 10.3%, respectively, in fiscal 2021. Increasing demand from both domestic and overseas customers, introduction of new products and stable realisations will support improvement in operating performance revenue growth and operating margin over the medium term. The financial risk profile will remain comfortable driven by limited reliance on external debt and healthy accretion. Capital expenditure (CAPEX) for setting up a unit in GIDC, Sayakha, at cost of around Rs 30 crore will be largely funded through internal accrual and hence financial risk profile should continue to remain comfortable despite the planned CAPEX. The ratings reflect the company’s established market position, diversified product portfolio and healthy financial risk profile. These strengths are partially offset by susceptibility to fluctuations in raw materials prices and large working capital requirement.

Key rating drivers and detailed description

Strengths:

  • Established market position and diversified product portfolio: Presence of over two decades in the organic chemicals industry and diversified geographical and customer profiles have enabled the company to establish strong market position. DFPL is among the leading players in all three business segments (key specialty chemicals, quaternary ammonium compounds [QAC] and quaternary phosphonium compounds [QPC]). It manufactures drug intermediates, quaternary compounds, organic specialties and active pharmaceutical ingredients (APIs). The company has been dealing with well-established customers such as Cipla Ltd and Dr Reddy’s Laboratories Ltd, Vesta Chemicals BV, Spectrum Dyes and Chemicals and has presence in both domestic and overaeas markets. The company has spread its presence in the overseas markets like Philippines, the US, China, Thailand, and South-East Asia. With introduction of new products, the revenue growth is expected to sustain over medium term as well.

 

  • Comfortable financial risk profile: Gearing remained below 1 time in the five fiscals ended March 31, 2022. The estimated net-worth was healthy at Rs 105.28 Crore as on March 31, 2022. Debt protection metrics were robust, with interest coverage ratio of 25.11 times and net cash accrual to adjusted debt of 1.54 times, in fiscal 2022. Despite capex for the new unit, the financial risk profile is expected to remain comfortable supported by healthy accretion and limited reliance on debt.

 

Weaknesses:

  • Susceptibility to fluctuations in raw material prices: As the cost of major raw materials (acetic acid and aniline oil) accounts for 75% of the production expense, volatility in prices can impact profitability in case of time lag in pass through. Absence of long-term contracts with suppliers further restricts the operating margin.

 

  • Moderately working capital intensive operations: Gross current assets were at 148 days as on March 31, 2022, driven by sizeable receivables of 106 days and modest inventory of 18 days. The working capital cycle is partly supported by payables of 68 days. Operations are likely to remain working capital intensive over the medium term.

Liquidity: Adequate

Bank limit utilisation was low at around 22% for the 12 months through May 2022. Cash accrual, expected above Rs 27 crore per annum, will sufficiently cover term debt obligation of Rs 2-3 crore over the medium term.


Current ratio was healthy at 2.02 times as on March 31, 2022. Low gearing and moderate networth support financial flexibility, which will cushion adverse conditions or downturns in the business.

Outlook: Stable

CRISIL Ratings believes DFPL will maintain comfortable financial risk profile and adequate liquidity over the medium term. The company will continue to benefit from its established market position and relationships with reputed clients.

Rating sensitivity factors

Upward factors

  • Sustained revenue growth and stable operating margin leading to healthy cash accruals of over Rs.30 crores on consistent basis.
  • Sustenance of the comfortable financial risk profile and surplus liquidity

 

Downward factors

  • Lower-than-expected revenue growth, resulting in cash accrual of less than Rs 20 crore per fiscal.
  • Large, debt-funded capex or further stretch in the working capital cycle leading to significant weakening the capital structure

About the company

DFPL was set up as a proprietary concern by Ms Sharayu D Deshmukh in 1978; the firm was reconstituted as a private limited company in 2000. Based in Nashik, Maharashtra, the company manufactures organic chemicals in three segments: key specialty chemicals, QAC and QPC, and drug intermediates.

Key Financial Indicators

As on / for the period ended March 31

 

2022*

2021

Operating income

Rs crore

306.00

243.77

Reported profit after tax

Rs crore

24.23

13.96

PAT margins

%

7.92

5.46

Adjusted Debt/Adjusted Net worth

Times

0.17

0.15

Interest coverage

Times

25.11

12.53

*Provisional

Note on complexity levels of the rated instrument:
CRISIL Ratings` complexity levels are assigned to various types of financial instruments and are included (where applicable) in the 'Annexure - Details of Instrument' in this Rating Rationale.

CRISIL Ratings will disclose complexity level for all securities - including those that are yet to be placed - based on available information. The complexity level for instruments may be updated, where required, in the rating rationale published subsequent to the issuance of the instrument when details on such features are available.

For more details on the CRISIL Ratings` complexity levels please visit www.crisilratings.com. Users may also call the Customer Service Helpdesk with queries on specific instruments.

Annexure - Details of Instrument(s)

ISIN

Name of instrument

Date of allotment

Coupon

rate (%)

Maturity date

Issue size

(Rs crore)

Complexity

level

Rating assigned

with outlook

NA

Cash Credit

NA

NA

NA

37.00

NA

CRISIL BBB+/Stable

NA

Proposed Long Term Bank Loan Facility

NA

NA

NA

37.05

NA

Withdrawn

NA

Foreign Letter of Credit

NA

NA

NA

8.00

NA

CRISIL A2

NA

Inland Letter of Credit

NA

NA

NA

4.00

NA

CRISIL A2

NA

Bank Guarantee

NA

NA

NA

2.50

NA

CRISIL A2

 

Annexure - Rating History for last 3 Years
  Current 2022 (History) 2021  2020  2019  Start of 2019
Instrument Type Outstanding Amount Rating Date Rating Date Rating Date Rating Date Rating Rating
Fund Based Facilities LT 74.05 CRISIL BBB+/Stable   -- 01-07-21 CRISIL A3+ / CRISIL BBB/Positive 15-07-20 CRISIL A3+ / CRISIL BBB/Stable 22-10-19 CRISIL A3+ / CRISIL BBB/Stable CRISIL BBB-/Positive / CRISIL A3
      --   --   -- 30-06-20 CRISIL A3+ / CRISIL BBB/Stable   -- CRISIL BBB-/Stable
Non-Fund Based Facilities ST 14.5 CRISIL A2   -- 01-07-21 CRISIL A3+ 15-07-20 CRISIL A3+ 22-10-19 CRISIL A3+ CRISIL A3
      --   --   -- 30-06-20 CRISIL A3+   -- --
All amounts are in Rs.Cr.
Annexure - Details of Bank Lenders & Facilities
Facility Amount (Rs.Crore) Name of Lender Rating
Bank Guarantee 2.5 State Bank of India CRISIL A2
Cash Credit 37 State Bank of India CRISIL BBB+/Stable
Foreign Letter of Credit 8 State Bank of India CRISIL A2
Inland/Import Letter of Credit 4 State Bank of India CRISIL A2
Proposed Long Term Bank Loan Facility 37.05 Not Applicable Withdrawn

This Annexure has been updated on 08-Feb-23 in line with the lender-wise facility details as on 17-Jan-23 received from the rated entity.

Criteria Details
Links to related criteria
CRISILs Approach to Financial Ratios
Rating criteria for manufaturing and service sector companies
CRISILs Bank Loan Ratings - process, scale and default recognition
Rating Criteria for Chemical Industry
CRISILs Criteria for rating short term debt

Media Relations
Analytical Contacts
Customer Service Helpdesk

Aveek Datta
Media Relations
CRISIL Limited
M: +91 99204 93912
B: +91 22 3342 3000
AVEEK.DATTA@crisil.com

Prakruti Jani
Media Relations
CRISIL Limited
M: +91 98678 68976
B: +91 22 3342 3000
PRAKRUTI.JANI@crisil.com

Rutuja Gaikwad 
Media Relations
CRISIL Limited
B: +91 22 3342 3000
Rutuja.Gaikwad@ext-crisil.com


Rahul Subrato Kumar Guha
Director
CRISIL Ratings Limited
D:+91 22 4097 8300
rahul.guha@crisil.com


Shirish A Mujumdar
Associate Director
CRISIL Ratings Limited
D:+91 20 4018 1934
shirish.mujumdar@crisil.com


Prateek Khare
Manager
CRISIL Ratings Limited
B:+91 20 4018 1900
Prateek.Khare@crisil.com
Timings: 10.00 am to 7.00 pm
Toll free Number:1800 267 1301

For a copy of Rationales / Rating Reports:
CRISILratingdesk@crisil.com
 
For Analytical queries:
ratingsinvestordesk@crisil.com


 

Note for Media:
This rating rationale is transmitted to you for the sole purpose of dissemination through your newspaper/magazine/agency. The rating rationale may be used by you in full or in part without changing the meaning or context thereof but with due credit to CRISIL Ratings. However, CRISIL Ratings alone has the sole right of distribution (whether directly or indirectly) of its rationales for consideration or otherwise through any media including websites and portals.


About CRISIL Ratings Limited (A subsidiary of CRISIL Limited, an S&P Global Company)

CRISIL Ratings pioneered the concept of credit rating in India in 1987. With a tradition of independence, analytical rigour and innovation, we set the standards in the credit rating business. We rate the entire range of debt instruments, such as bank loans, certificates of deposit, commercial paper, non-convertible/convertible/partially convertible bonds and debentures, perpetual bonds, bank hybrid capital instruments, asset-backed and mortgage-backed securities, partial guarantees and other structured debt instruments. We have rated over 33,000 large and mid-scale corporates and financial institutions. We have also instituted several innovations in India in the rating business, including ratings for municipal bonds, partially guaranteed instruments and infrastructure investment trusts (InvITs).
 
CRISIL Ratings Limited ('CRISIL Ratings') is a wholly-owned subsidiary of CRISIL Limited ('CRISIL'). CRISIL Ratings Limited is registered in India as a credit rating agency with the Securities and Exchange Board of India ("SEBI").
 
For more information, visit www.crisilratings.com 

 



About CRISIL Limited

CRISIL is a leading, agile and innovative global analytics company driven by its mission of making markets function better. 

It is India’s foremost provider of ratings, data, research, analytics and solutions with a strong track record of growth, culture of innovation, and global footprint.

It has delivered independent opinions, actionable insights, and efficient solutions to over 100,000 customers through businesses that operate from India, the US, the UK, Argentina, Poland, China, Hong Kong and Singapore.

It is majority owned by S&P Global Inc, a leading provider of transparent and independent ratings, benchmarks, analytics and data to the capital and commodity markets worldwide.

For more information, visit www.crisil.com

Connect with us: TWITTER | LINKEDIN | YOUTUBE | FACEBOOK


CRISIL PRIVACY NOTICE
 
CRISIL respects your privacy. We may use your contact information, such as your name, address and email id to fulfil your request and service your account and to provide you with additional information from CRISIL. For further information on CRISIL's privacy policy please visit www.crisil.com.



DISCLAIMER

This disclaimer is part of and applies to each credit rating report and/or credit rating rationale ('report') that is provided by CRISIL Ratings Limited ('CRISIL Ratings'). To avoid doubt, the term 'report' includes the information, ratings and other content forming part of the report. The report is intended for the jurisdiction of India only. This report does not constitute an offer of services. Without limiting the generality of the foregoing, nothing in the report is to be construed as CRISIL Ratings providing or intending to provide any services in jurisdictions where CRISIL Ratings does not have the necessary licenses and/or registration to carry out its business activities referred to above. Access or use of this report does not create a client relationship between CRISIL Ratings and the user.

We are not aware that any user intends to rely on the report or of the manner in which a user intends to use the report. In preparing our report we have not taken into consideration the objectives or particular needs of any particular user. It is made abundantly clear that the report is not intended to and does not constitute an investment advice. The report is not an offer to sell or an offer to purchase or subscribe for any investment in any securities, instruments, facilities or solicitation of any kind to enter into any deal or transaction with the entity to which the report pertains. The report should not be the sole or primary basis for any investment decision within the meaning of any law or regulation (including the laws and regulations applicable in the US).

Ratings from CRISIL Ratings are statements of opinion as of the date they are expressed and not statements of fact or recommendations to purchase, hold or sell any securities/instruments or to make any investment decisions. Any opinions expressed here are in good faith, are subject to change without notice, and are only current as of the stated date of their issue. CRISIL Ratings assumes no obligation to update its opinions following publication in any form or format although CRISIL Ratings may disseminate its opinions and analysis. The rating contained in the report is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment or other business decisions. The recipients of the report should rely on their own judgment and take their own professional advice before acting on the report in any way. CRISIL Ratings or its associates may have other commercial transactions with the entity to which the report pertains.

Neither CRISIL Ratings nor its affiliates, third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively, 'CRISIL Ratings Parties') guarantee the accuracy, completeness or adequacy of the report, and no CRISIL Ratings Party shall have any liability for any errors, omissions or interruptions therein, regardless of the cause, or for the results obtained from the use of any part of the report. EACH CRISIL RATINGS PARTY DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING BUT NOT LIMITED TO ANY WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall any CRISIL Ratings Party be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of any part of the report even if advised of the possibility of such damages.

CRISIL Ratings may receive compensation for its ratings and certain credit-related analyses, normally from issuers or underwriters of the instruments, facilities, securities or from obligors. Public ratings and analysis by CRISIL Ratings, as are required to be disclosed under the regulations of the Securities and Exchange Board of India (and other applicable regulations, if any), are made available on its website, www.crisilratings.com (free of charge). Reports with more detail and additional information may be available for subscription at a fee - more details about ratings by CRISIL Ratings are available here: www.crisilratings.com.

CRISIL Ratings and its affiliates do not act as a fiduciary. While CRISIL Ratings has obtained information from sources it believes to be reliable, CRISIL Ratings does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives and/or relies on in its reports. CRISIL Ratings has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process. CRISIL Ratings has in place a ratings code of conduct and policies for managing conflict of interest. For details please refer to:
https://www.crisil.com/en/home/our-businesses/ratings/regulatory-disclosures/highlighted-policies.html.

Rating criteria by CRISIL Ratings are generally available without charge to the public on the CRISIL Ratings public website, www.crisilratings.com. For latest rating information on any instrument of any company rated by CRISIL Ratings, you may contact the CRISIL Ratings desk at crisilratingdesk@crisil.com, or at (0091) 1800 267 1301.

This report should not be reproduced or redistributed to any other person or in any form without prior written consent from CRISIL Ratings.

All rights reserved @ CRISIL Ratings Limited. CRISIL Ratings is a wholly owned subsidiary of CRISIL Limited.

 

 

CRISIL Ratings uses the prefix 'PP-MLD' for the ratings of principal-protected market-linked debentures (PPMLD) with effect from November 1, 2011, to comply with the SEBI circular, "Guidelines for Issue and Listing of Structured Products/Market Linked Debentures". The revision in rating symbols for PPMLDs should not be construed as a change in the rating of the subject instrument. For details on CRISIL Ratings' use of 'PP-MLD' please refer to the notes to Rating scale for Debt Instruments and Structured Finance Instruments at the following link: https://www.crisil.com/en/home/our-businesses/ratings/credit-ratings-scale.html